Page last updated: 2024-08-23

2-amino-3-methylimidazo(4,5-f)quinoline and transforming growth factor beta

2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with transforming growth factor beta in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakehashi, A; Tajiri, M; Wanibuchi, H; Wei, M; Xie, XL; Yamano, S1

Other Studies

1 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and transforming growth factor beta

ArticleYear
2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways.
    Toxicological sciences : an official journal of the Society of Toxicology, 2012, Volume: 125, Issue:2

    Topics: Animals; beta Catenin; Blotting, Western; Body Weight; Carcinoma, Hepatocellular; Cell Adhesion; Cell Transformation, Neoplastic; Diethylnitrosamine; Dose-Response Relationship, Drug; Drinking; Eating; Hepatectomy; Immunohistochemistry; Liver; Liver Neoplasms, Experimental; Male; Mice; Organ Size; Quinolines; Time Factors; Transforming Growth Factor beta; Wnt Proteins; Wnt Signaling Pathway

2012